Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.
about
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineImmunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro.Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.Personalized cancer immunotherapy using Systems Medicine approaches.Vaccines targeting helper T cells for cancer immunotherapy.ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging.HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.Role of liver ICAM-1 in metastasis.PD1 functions by inhibiting CD28-mediated co-stimulation.Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival.Neoantigen prediction and the need for validation.Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity.Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination.N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients - association with tumor biology and clinical outcome.Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial.
P2860
Q26782583-4B0D0D0E-E668-4DCC-A92E-6D3124E5C49AQ36073299-A0AAFFEB-F4C7-4DB6-9ED9-B124ECAAB96AQ37012876-AEE3EA30-7C99-440E-BAA8-86D7578A4745Q37616492-856771FE-C8E2-4A0E-B662-C20C4615EC87Q38547040-BF3158C0-60AD-4099-8C9B-6F7D415D7A54Q38649958-878728DA-95D8-4DDB-9895-C55C29908345Q38783061-1B381862-149B-4D77-AF14-C98D7C4C8305Q39201713-3C60EF87-EBE5-4255-8025-3A910E85737DQ40774020-761A7431-7C35-4E5E-A59B-F21DFC1AA82EQ41701847-B0F3573B-4177-4F67-A03D-2498CF0AEC0EQ42332962-C7BE5DA1-C080-4ED6-96E5-580F0C050109Q42639856-C055E943-DAF9-49C8-97CC-623E9899762AQ46969749-42FD438C-1C7C-45BD-B012-95FB732633A1Q48170351-5363E288-C4A7-40E3-8BD3-26AE63CBA33DQ49013708-A25229AA-426B-41DB-BB89-A2EA542F304FQ52308791-66710448-9C52-45AE-A52C-5187FC34780DQ55235076-2CFA6FC2-7AA2-440D-8316-8969E49D88C9
P2860
Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.
@en
type
label
Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.
@en
prefLabel
Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.
@en
P356
P1476
Tapping CD4 T cells for cancer immunotherapy: the choice of personalized genomics.
@en
P2093
Maurizio Zanetti
P304
P356
10.4049/JIMMUNOL.1402669
P407
P577
2015-03-01T00:00:00Z